Objectives This study assessed cat owners’ perceptions of the use of psychoactive medications and alternative products for the treatment of behavioral problems in their cats. Factors that potentially impact these perceptions were explored and discussed. Methods An online, anonymous, cross-sectional survey was conducted to assess US-based cat owners’ experiences with behavior problems of their cats, familiarity with psychoactive medications for treatment of behavior problems and comfort levels using the following products for treatment of feline behavior problems: fast-acting or situational prescription medications, slow-acting or long-term prescription medications, herbal/nutritional supplements, pheromone products and cannabinoid products. Results Many respondents reported that their cats had behavioral problems, but few had ever sought behavioral help for their cats. Only half were aware of the availability of psychoactive medications for cat behavior problems. Respondents who had personally used a prescription psychoactive medication in the past were more comfortable with giving fast- and slow-acting prescription medications, pheromone products and cannabinoids to their cats than respondents who had never used a prescription psychoactive medication. No difference in comfort level was seen for herbal/nutritional supplements. Overall, owners tended to be more comfortable with the situational vs long-term medications. Conclusions and relevance Given the prevalence of feline behavior problems reported in this study, the lack of awareness of either the availability or potential benefits of psychoactive medications for the treatment of feline behavior problems, and the fact that very few owners had ever sought help for behavior problems with their cats, are concerning. These results suggest a missed opportunity for veterinarians to help clients identify, understand and treat feline behavior problems. Many owners appear open to these treatment options for their cats; it is suggested that, when warranted, educating cat owners about the potential benefits and risks of these medications would be of value.

Over 1 million dogs are imported into the United States and roughly 340,000 dogs into the United Kingdom yearly. Although the official number of dogs arriving to Canada is currently unknown, local animal professionals estimate that thousands of dogs are imported into Canada each year. Dog importation may be increasing globally while regulation and surveillance are still limited, resulting in concerns for the health and welfare of imported dogs. To date, few studies have investigated how the source location of dogs influences the owner-dog relationship. The current report presents two independent studies that were conducted to assess whether owners of imported dogs reported a poorer owner-dog relationships compared to owners of Canadian-born dogs. In both studies, an online survey was distributed to dog owners (Study 1: n = 803; Study 2: n = 878) in British Columbia, Canada, containing questions on various aspects of the owner-dog relationship. The first study included questions from the Lexington Attachment to Pets Scale, Canine Behavioral Assessment and Research Questionnaire, Human-Animal Bond questionnaire, Monash Dog Owner Relationship Scale, and constructed questions about training methods, expectations, and health. The second study was comprised of original questions assessing difficult behaviour, training practices, health, attachment, and perceived level of burden of owning a dog. Both studies found no evidence of a poorer owner-dog relationship in non-Canadian-sourced dogs. In fact, owners of Canadian-sourced dogs used harsh training methods more frequently and had higher expectations for their dog. While no signs of poorer owner-dog relationship in non-Canadian-sourced dogs were found, future research should continue the investigation of age, health, and backgrounds of incoming dogs.

Objectives The aim of this study was to determine whether there was an increase in cat relinquishment for destructive scratching behavior, a change in overall feline surrender intake and euthanasia, or a change in average length of stay in a British Columbia shelter system after provincial legislation banning elective onychectomy. Methods Records of cats admitted to the British Columbia Society for the Prevention of Cruelty to Animals in the 36 months prior to (1 May 2015–30 April 2018, n = 41,157) and after (1 May 2018–30 April 2021, n = 33,430) the provincial ban on elective onychectomy were reviewed. Total intake numbers, euthanasia and length of stay were descriptively compared between periods. Proportions of cats and kittens surrendered for destructive scratching, as well as the proportion of cats and kittens surrendered with an owner request for euthanasia, were compared using two-sample z-tests of proportions. Results Destructive behavior was found to be an uncommon reason for surrender (0.18% of surrendered cats) during the study period. There was no statistically significant difference in the number of cats surrendered for destructive scratching behavior ( z = −1.89, P >0.05) after the provincial ban on elective onychectomy. On the contrary, the proportion of owner-requested euthanasias decreased after the ban ( z = 3.90, P <0.001). The total number of cats surrendered, the shelter live release rate and average length of stay all remained stable or improved following the ban, though causation could not be determined. Conclusions and relevance The findings in this study suggest that legislation banning elective onychectomy does not increase the risk of feline shelter relinquishment – for destructive behavior or overall – and is unlikely to have a significant effect on shelter euthanasia or length of stay.

OBJECTIVE To evaluate the impact of daily gabapentin on behavior modification progression and signs of stress in fearful shelter cats from hoarding environments. ANIMALS 37 cats (32 met inclusion criteria). PROCEDURES Healthy fearful cats were entered into group (1) gabapentin or (2) placebo upon intake. Both groups received daily behavior modification. Cats received 10 mg/kg of liquid gabapentin or placebo every 12 hours. Daily measures of cat stress score, latency to emerge from hiding, general in-shelter behavior, and urine suppression were collected. Results were analyzed on an intention-to-treat and per-protocol basis (including only cats that received > 75% of their doses). Post-adoption surveys assessed cat social behavior. RESULTS Of 32 fearful cats, 28 (87.5%) graduated from the behavior modification program in a median of 11 days (range, 4 to 51 days). Per-protocol analysis showed that gabapentin predicted quicker behavior modification progression and lower cat stress score, latency to emerge, and urine suppression compared to placebo. Median time to graduation was reduced by half with gabapentin. Intention-to-treat analysis showed that gabapentin predicted a lower cat stress score and latency to emerge. No differences were observed between groups for general in-shelter behavior. Among limited survey respondents (n = 7), despite showing unsocial behavior in the first week and among unfamiliar people, cats showed social behavior 1 year post-adoption. CLINICAL RELEVANCE Daily gabapentin was beneficial in behavior modification progress and reduced signs of stress in shelter cats. Fearful cats from hoarding environments can be successfully treated with behavior modification ± daily gabapentin within an animal shelter.